Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV)

Historical Holders from Q2 2021 to Q3 2025

Symbol
ELEV
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
62.3M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2K
Holdings value
$720
Grand Portfolio weight change
0%
Number of holders
1
Number of sells
-60
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 7% $1.64M 4.44M BVF PARTNERS L P/IL 31 Mar 2025
TANG CAPITAL MANAGEMENT LLC 5% -49.9% $1.18M -$1.11M 3.12M -48.5% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
VANGUARD GROUP INC 4.41% $966K 2.61M The Vanguard Group 31 Dec 2024
GOLDMAN SACHS GROUP INC 2.8% $623K 1.68M THE GOLDMAN SACHS GROUP, INC. 31 Dec 2024
BlackRock, Inc. 0.6% -96% $135K -$1.03M 369K -88.3% BlackRock, Inc. 30 Jun 2025

Institutional Holders of Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2K $720 -$10.8M $0.36 1
2025 Q2 29.5M $10.8M -$794K $0.37 62
2025 Q1 33.8M $8.76M -$4.44M $0.26 70
2024 Q4 40M $22.5M -$3.75M $0.56 70
2024 Q3 45.9M $27.6M -$42.3M $0.60 67
2024 Q2 52.1M $140M +$17.1M $2.70 79
2024 Q1 44M $226M +$110M $5.13 61
2023 Q4 25.8M $13.9M -$1.44M $0.54 31
2023 Q3 28M $18.6M -$5.58M $0.66 40
2023 Q2 31.5M $48.8M +$23M $1.52 38
2023 Q1 16.2M $30.9M +$3.77M $1.90 27
2022 Q4 14.4M $13.7M +$91.7K $0.95 26
2022 Q3 14.3M $16.1M -$1.53M $1.13 21
2022 Q2 15.4M $21.5M -$7.04M $1.40 24
2022 Q1 18.7M $47.2M +$632K $2.52 28
2021 Q4 15.9M $95.9M -$3.12M $6.02 33
2021 Q3 15.9M $123M -$8.55M $7.79 21
2021 Q2 16.2M $217M +$217M $13.57 35